{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:00:50Z","timestamp":1762009250485,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.atherosclerosis.2019.01.019","type":"journal-article","created":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T12:46:34Z","timestamp":1548506794000},"page":"260-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The \u201ccholesterol paradox\u201d in patients with mastocytosis"],"prefix":"10.1016","volume":"284","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2421-1710","authenticated-orcid":false,"given":"Raimondo","family":"Femin\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Femin\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2019.01.019_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.atherosclerosis.2017.11.030","article-title":"Systemic mastocytosis associates with cardiovascular events despite lower plasma lipid levels","volume":"268","author":"Indhirajanti","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2019.01.019_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4939-1568-2_8","article-title":"The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling","volume":"1220","author":"Janicki","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2019.01.019_bib3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1253\/circj.CJ-12-0308","article-title":"The cholesterol paradox in atrial fibrillation","volume":"76","author":"Femin\u00f2","year":"2012","journal-title":"Circ. J."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.01.019_bib4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1189\/jlb.3RU0316-151R","article-title":"Endotoxemia-menace, marker, or mistake?","volume":"100","author":"Munford","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2019.01.019_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/clc.22864","article-title":"Lipid profile and incidence of atrial fibrillation: a prospective cohort study in China","volume":"41","author":"Li","year":"2018","journal-title":"Clin. Cardiol."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2019.01.019_bib6","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.2169\/internalmedicine.53.2672","article-title":"Relationships between the serum cholesterol levels, production of monocyte proinflammatory cytokines and long-term prognosis in patients with chronic heart failure","volume":"53","author":"Nakagomi","year":"2014","journal-title":"Intern. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2019.01.019_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.117.241976","article-title":"S1P receptor 1-mediated anti-renin-angiotensin system cardioprotection: pivotal role of mast cell aldehyde dehydrogenase type 2","volume":"362","author":"Marino","year":"2017","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2019.01.019_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","article-title":"Immune functions of serum amyloid A","volume":"32","author":"Eklund","year":"2012","journal-title":"Crit. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2019.01.019_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.E012138","article-title":"The role of HDL in innate immunity","volume":"52","author":"Feingold","year":"2011","journal-title":"J. Lipid Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019300322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915019300322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:40:30Z","timestamp":1758156030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915019300322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":9,"alternative-id":["S0021915019300322"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.019","relation":{},"ISSN":["0021-9150"],"issn-type":[{"type":"print","value":"0021-9150"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The \u201ccholesterol paradox\u201d in patients with mastocytosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2019.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.11.030","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}